FDA Device Intelligence
HomeDevice types › NTI

Drug Metabolizing Enzyme Genotyping Systems

FDA product code NTI · Class 2 · Clinical Toxicology

22
Registered devices
6
Adverse events
4
Recalls
11
510(k) clearances

Devices with this code

Recent recalls

DateFirmReason
2014-03-18Nanosphere, Inc.Nanosphere has recieved reports related to an unacceptable increase in initial no-call rate when performing the Verigene CYP2C19 Nucleic Acid Test (2C19), which
2011-05-24Luminex CorporationInaccurate test results, due to possible defective primers, which could lead to incorrect dosage on manufactured drug assays.
2007-03-09Roche Molecular Systems, Inc.The current package insert for the AmpliChip CYP 450 test, lists an incorrect part number for DNase I. The DNase is listed in the "Other Materials Required" se
2007-03-09Roche Molecular Systems, Inc.The current package insert for the AmpliChip CYP 450 test, lists an incorrect part number for DNase I. The DNase is listed in the "Other Materials Required" se

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Sourced from public U.S. FDA data. Informational only — not medical or regulatory advice. Not affiliated with the FDA.